Nouscom Appoints Adrian Woolfson as CMONouscom, an immuno-oncology company developing off-the-shelf and personalized neoantigen-based genetic cancer vaccines, announced today the appointment of Adrian Woolfson M.D., Ph.D. as Chief Medical … more ➔
Aldevron Names Marc Wolff CFOMarc Wolff has been named Chief Financial Officer of Aldevron, a provider of plasmid DNA manufacturing, protein production and antibody discovery services. Mr. Wolff will lead the global finance and … more ➔
Horizon Discovery appoints Terry Pizzie as CEOHorizon Discovery Group plc has announced the appointment of Terry Pizzie as Chief Executive Officer and Board Director with immediate effect. more ➔
Bayer announces new Crop Science Leadership TeamBayer today announced the selection of the new Executive Leadership Team for the Crop Science division, which will go into effect as of the closing of Bayer’s proposed acquisition of Monsanto. The closing … more ➔
Sonde Health Adds Thai Lee to Board of DirectorsSonde Health Inc., an affiliate of PureTech Health (PureTech Health plc, PRTC.L) developing a voice-based technology platform for monitoring and diagnosing mental and physical medical conditions, today … more ➔
Neurimmune Appoints Fabian Buller as CBONeurimmune today announced that it has appointed Dr. Fabian Buller to the newly created position Chief Business Officer. Dr. Buller joins Neurimmune’s executive team and brings 8 years of professional … more ➔
Concept appoints Matilda Bingham & David HigtonConcept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Matilda Bingham as Site Director of its Alderley Park site … more ➔
Redx appoints Lisa Anson as new Chief Executive OfficerRedx Pharma announced today that it has appointed Lisa Anson as Chief Executive Officer (CEO) and to its Board of Directors. Lisa will take up both roles on 1 June 2018. At that time Iain Ross, currently … more ➔
Sanofi names John Reed as new Head of Global R&DElias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the … more ➔
Sanofi names John Reed as new Head of Global R&DElias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the … more ➔
